{"id":"https://openalex.org/W3119728070","doi":"https://doi.org/10.1093/ofid/ofaa439.1794","title":"1614. Gwt1 Inhibitor, APX2104, Protects Against Invasive Aspergillosis in Neutropenic Mouse Model","display_name":"1614. Gwt1 Inhibitor, APX2104, Protects Against Invasive Aspergillosis in Neutropenic Mouse Model","publication_year":2020,"publication_date":"2020-10-01","ids":{"openalex":"https://openalex.org/W3119728070","doi":"https://doi.org/10.1093/ofid/ofaa439.1794","mag":"3119728070"},"language":"en","primary_location":{"id":"doi:10.1093/ofid/ofaa439.1794","doi":"https://doi.org/10.1093/ofid/ofaa439.1794","is_oa":true,"landing_page_url":"https://doi.org/10.1093/ofid/ofaa439.1794","pdf_url":null,"source":{"id":"https://openalex.org/S2735126445","display_name":"Open Forum Infectious Diseases","issn_l":"2328-8957","issn":["2328-8957"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","doyens","jufo-1","ki-jl-1","norway-1","poland-100","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310311648","host_organization_name":"Oxford University Press","host_organization_lineage":["https://openalex.org/P4310311648","https://openalex.org/P4310311647"],"host_organization_lineage_names":["Oxford University Press","University of Oxford"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Open Forum Infectious Diseases","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","doaj"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://doi.org/10.1093/ofid/ofaa439.1794","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5067614603","display_name":"Shareef K. Shaheen","orcid":"https://orcid.org/0000-0001-9429-2451","observed_orcids":["https://orcid.org/0000-0001-9429-2451"]},"institutions":[{"id":"https://openalex.org/I4210126298","display_name":"Duke Medical Center","ror":"https://ror.org/03njmea73","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210126298","https://openalex.org/I4210144876"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Shareef Shaheen","raw_affiliation_strings":["Duke University Medical Center, Durham, North Carolina"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Duke University Medical Center, Durham, North Carolina","institution_ids":["https://openalex.org/I4210126298"]}]},{"author_position":"middle","author":{"id":null,"display_name":"John Allen","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210126298","display_name":"Duke Medical Center","ror":"https://ror.org/03njmea73","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210126298","https://openalex.org/I4210144876"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"John Allen","raw_affiliation_strings":["Duke University Medical Center, Durham, North Carolina"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Duke University Medical Center, Durham, North Carolina","institution_ids":["https://openalex.org/I4210126298"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5030067295","display_name":"David E. C. Cole","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210126298","display_name":"Duke Medical Center","ror":"https://ror.org/03njmea73","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210126298","https://openalex.org/I4210144876"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"D Chris Cole","raw_affiliation_strings":["Duke University Medical Center, Durham, North Carolina"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Duke University Medical Center, Durham, North Carolina","institution_ids":["https://openalex.org/I4210126298"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5023876631","display_name":"Yohannes G. Asfaw","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I170897317","display_name":"Duke University","ror":"https://ror.org/00py81415","country_code":"US","type":"education","lineage":["https://openalex.org/I170897317"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Yohannes Asfaw","raw_affiliation_strings":["Duke University, Durham, North Carolina"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Duke University, Durham, North Carolina","institution_ids":["https://openalex.org/I170897317"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5015691337","display_name":"Praveen R. Juvvadi","orcid":"https://orcid.org/0000-0002-5112-7824","observed_orcids":["https://orcid.org/0000-0002-5112-7824"]},"institutions":[{"id":"https://openalex.org/I4210126298","display_name":"Duke Medical Center","ror":"https://ror.org/03njmea73","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210126298","https://openalex.org/I4210144876"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Praveen Juvvadi","raw_affiliation_strings":["Duke University Medical Center, Durham, North Carolina"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Duke University Medical Center, Durham, North Carolina","institution_ids":["https://openalex.org/I4210126298"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5057337386","display_name":"Elliot Keats Shwab","orcid":"https://orcid.org/0000-0002-8383-1031","observed_orcids":["https://orcid.org/0000-0002-8383-1031"]},"institutions":[{"id":"https://openalex.org/I4210126298","display_name":"Duke Medical Center","ror":"https://ror.org/03njmea73","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210126298","https://openalex.org/I4210144876"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"E Keats Shwab","raw_affiliation_strings":["Duke University Medical Center, Durham, North Carolina"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Duke University Medical Center, Durham, North Carolina","institution_ids":["https://openalex.org/I4210126298"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5068879729","display_name":"Mili Kapoor","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210108517","display_name":"Amplyx Pharmaceuticals (United States)","ror":"https://ror.org/02jfsdq79","country_code":"US","type":"company","lineage":["https://openalex.org/I4210108517"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Mili Kapoor","raw_affiliation_strings":["Amplyx Pharmaceuticals, San Diego, California"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Amplyx Pharmaceuticals, San Diego, California","institution_ids":["https://openalex.org/I4210108517"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5086601088","display_name":"Karen Joy Shaw","orcid":"https://orcid.org/0000-0003-3060-1328","observed_orcids":["https://orcid.org/0000-0003-3060-1328"]},"institutions":[{"id":"https://openalex.org/I4210108517","display_name":"Amplyx Pharmaceuticals (United States)","ror":"https://ror.org/02jfsdq79","country_code":"US","type":"company","lineage":["https://openalex.org/I4210108517"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Karen Shaw","raw_affiliation_strings":["Amplyx Pharmaceuticals, San Diego, California"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Amplyx Pharmaceuticals, San Diego, California","institution_ids":["https://openalex.org/I4210108517"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5056810823","display_name":"William J. Steinbach","orcid":"https://orcid.org/0000-0002-5446-1094","observed_orcids":["https://orcid.org/0000-0002-5446-1094"]},"institutions":[{"id":"https://openalex.org/I170897317","display_name":"Duke University","ror":"https://ror.org/00py81415","country_code":"US","type":"education","lineage":["https://openalex.org/I170897317"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"William Steinbach","raw_affiliation_strings":["Duke University, Durham, North Carolina"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Duke University, Durham, North Carolina","institution_ids":["https://openalex.org/I170897317"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":3,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":4053,"currency":"USD","value_usd":4053},"apc_paid":{"value":4053,"currency":"USD","value_usd":4053},"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.20323657,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"7","issue":"Supplement_1","first_page":"S800","last_page":"S801"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10150","display_name":"Antifungal resistance and susceptibility","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10150","display_name":"Antifungal resistance and susceptibility","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10497","display_name":"Fungal and yeast genetics research","score":0.0,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11900","display_name":"Fungal Plant Pathogen Control","score":0.0,"subfield":{"id":"https://openalex.org/subfields/1105","display_name":"Ecology, Evolution, Behavior and Systematics"},"field":{"id":"https://openalex.org/fields/11","display_name":"Agricultural and Biological Sciences"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/invasive-aspergillosis","display_name":"invasive aspergillosis","score":0.9649999737739563},{"id":"https://openalex.org/keywords/aspergillus-fumigatus","display_name":"Aspergillus fumigatus","score":0.9959999918937683},{"id":"https://openalex.org/keywords/neutropenia","display_name":"neutropenia","score":0.6019999980926514},{"id":"https://openalex.org/keywords/immunocompromised-patients","display_name":"immunocompromised patients","score":0.7850000262260437},{"id":"https://openalex.org/keywords/antifungal-resistance","display_name":"antifungal resistance","score":0.7739999890327454},{"id":"https://openalex.org/keywords/echinocandin-resistance","display_name":"echinocandin resistance","score":0.8550000190734863},{"id":"https://openalex.org/keywords/azole-resistance","display_name":"azole resistance","score":0.7329999804496765},{"id":"https://openalex.org/keywords/voriconazole","display_name":"voriconazole","score":0.6890000104904175},{"id":"https://openalex.org/keywords/caspofungin","display_name":"caspofungin","score":0.9980000257492065},{"id":"https://openalex.org/keywords/amphotericin-b","display_name":"amphotericin B","score":0.9900000095367432},{"id":"https://openalex.org/keywords/posaconazole","display_name":"posaconazole","score":0.8119999766349792},{"id":"https://openalex.org/keywords/antifungal-toxicity","display_name":"antifungal toxicity","score":0.515999972820282}],"concepts":[{"id":"https://openalex.org/C2780690907","wikidata":"https://www.wikidata.org/wiki/Q412236","display_name":"Voriconazole","level":3,"score":0.8471857309341431},{"id":"https://openalex.org/C2780402444","wikidata":"https://www.wikidata.org/wiki/Q420875","display_name":"Caspofungin","level":4,"score":0.8379509449005127},{"id":"https://openalex.org/C2779787849","wikidata":"https://www.wikidata.org/wiki/Q134359","display_name":"Aspergillus fumigatus","level":2,"score":0.7783498764038086},{"id":"https://openalex.org/C2779320740","wikidata":"https://www.wikidata.org/wiki/Q3718510","display_name":"Echinocandin","level":4,"score":0.7653658390045166},{"id":"https://openalex.org/C2779629538","wikidata":"https://www.wikidata.org/wiki/Q412223","display_name":"Amphotericin B","level":3,"score":0.6818124055862427},{"id":"https://openalex.org/C2776391196","wikidata":"https://www.wikidata.org/wiki/Q259626","display_name":"Aspergillosis","level":2,"score":0.6609686613082886},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.6443442106246948},{"id":"https://openalex.org/C2777063308","wikidata":"https://www.wikidata.org/wiki/Q1435822","display_name":"Neutropenia","level":3,"score":0.583484947681427},{"id":"https://openalex.org/C2778566413","wikidata":"https://www.wikidata.org/wiki/Q906453","display_name":"Posaconazole","level":4,"score":0.5711752772331238},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.5635998845100403},{"id":"https://openalex.org/C207001950","wikidata":"https://www.wikidata.org/wiki/Q141124","display_name":"In vivo","level":2,"score":0.4279814660549164},{"id":"https://openalex.org/C2779020398","wikidata":"https://www.wikidata.org/wiki/Q6827850","display_name":"Micafungin","level":4,"score":0.4128100872039795},{"id":"https://openalex.org/C89423630","wikidata":"https://www.wikidata.org/wiki/Q7193","display_name":"Microbiology","level":1,"score":0.4020371735095978},{"id":"https://openalex.org/C29730261","wikidata":"https://www.wikidata.org/wiki/Q274160","display_name":"Toxicity","level":2,"score":0.3905382752418518},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.2019788920879364},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.1986880600452423},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.17061296105384827},{"id":"https://openalex.org/C2779548794","wikidata":"https://www.wikidata.org/wiki/Q578726","display_name":"Antifungal","level":2,"score":0.13842537999153137},{"id":"https://openalex.org/C2780651595","wikidata":"https://www.wikidata.org/wiki/Q411478","display_name":"Fluconazole","level":3,"score":0.10709872841835022},{"id":"https://openalex.org/C16005928","wikidata":"https://www.wikidata.org/wiki/Q171171","display_name":"Dermatology","level":1,"score":0.0},{"id":"https://openalex.org/C150903083","wikidata":"https://www.wikidata.org/wiki/Q7108","display_name":"Biotechnology","level":1,"score":0.0}],"mesh":[],"locations_count":3,"locations":[{"id":"doi:10.1093/ofid/ofaa439.1794","doi":"https://doi.org/10.1093/ofid/ofaa439.1794","is_oa":true,"landing_page_url":"https://doi.org/10.1093/ofid/ofaa439.1794","pdf_url":null,"source":{"id":"https://openalex.org/S2735126445","display_name":"Open Forum Infectious Diseases","issn_l":"2328-8957","issn":["2328-8957"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","doyens","jufo-1","ki-jl-1","norway-1","poland-100","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310311648","host_organization_name":"Oxford University Press","host_organization_lineage":["https://openalex.org/P4310311648","https://openalex.org/P4310311647"],"host_organization_lineage_names":["Oxford University Press","University of Oxford"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Open Forum Infectious Diseases","raw_type":"journal-article"},{"id":"pmh:oai:europepmc.org:6698627","doi":null,"is_oa":true,"landing_page_url":"http://europepmc.org/pmc/articles/PMC7777865","pdf_url":null,"source":{"id":"https://openalex.org/S4306400806","display_name":"Europe PMC (PubMed Central)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1303153112","host_organization_name":"European Bioinformatics Institute","host_organization_lineage":["https://openalex.org/I1303153112"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"","raw_type":"Text"},{"id":"pmh:oai:pubmedcentral.nih.gov:7777865","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/7777865","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Open Forum Infect Dis","raw_type":"Text"}],"best_oa_location":{"id":"doi:10.1093/ofid/ofaa439.1794","doi":"https://doi.org/10.1093/ofid/ofaa439.1794","is_oa":true,"landing_page_url":"https://doi.org/10.1093/ofid/ofaa439.1794","pdf_url":null,"source":{"id":"https://openalex.org/S2735126445","display_name":"Open Forum Infectious Diseases","issn_l":"2328-8957","issn":["2328-8957"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","doyens","jufo-1","ki-jl-1","norway-1","poland-100","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310311648","host_organization_name":"Oxford University Press","host_organization_lineage":["https://openalex.org/P4310311648","https://openalex.org/P4310311647"],"host_organization_lineage_names":["Oxford University Press","University of Oxford"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Open Forum Infectious Diseases","raw_type":"journal-article"},"sustainable_development_goals":[{"score":1.0,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W3184138977","https://openalex.org/W3125346374","https://openalex.org/W2337561576","https://openalex.org/W2091154493","https://openalex.org/W2900712152","https://openalex.org/W2101438344","https://openalex.org/W2129942501","https://openalex.org/W2115510497","https://openalex.org/W2142632979","https://openalex.org/W2911592729"],"abstract_inverted_index":{"Abstract":[0],"Background":[1],"Aspergillus":[2],"fumigatus":[3,75,126,172],"is":[4,23,331],"the":[5,148,295,303,311],"leading":[6],"cause":[7],"of":[8,84,96,104,121,124,131,150,212,251,265,267,297,313],"invasive":[9],"aspergillosis":[10],"(IA),":[11],"a":[12,24,129,154,210,221,263,332],"lethal":[13],"infection":[14],"among":[15],"immunocompromised":[16,87,190],"patients.":[17],"Guideline-recommended":[18],"antifungal":[19,42,319,341],"therapy":[20],"against":[21,72,169,317],"IA":[22,337],"triazole":[25],"antifungal,":[26],"with":[27,93,235,277],"other":[28],"secondary":[29],"options":[30],"including":[31,174],"an":[32,115],"echinocandin":[33],"and":[34,41,51,69,82,101,140,166,176,195,282,315,339],"amphotericin":[35,70,167],"B.":[36],"Concerns":[37],"about":[38],"drug-host":[39],"toxicity":[40,81,205],"resistance":[43],"have":[44],"been":[45],"globally":[46],"reported,":[47],"so":[48,215],"new,":[49],"safe,":[50],"effective":[52,158],"therapeutics":[53],"are":[54],"imperative.":[55],"Methods":[56],"In":[57,77,145,179,230],"vitro,":[58,146],"CLSI":[59],"standards":[60],"were":[61,112,206],"upheld":[62],"as":[63,220,324],"we":[64,79],"tested":[65,187],"APX2041,":[66,147],"voriconazole,":[67,164],"caspofungin,":[68,165],"B":[71,168],"various":[73,170],"A.":[74,125,171],"strains.":[76,178],"vivo":[78,227],"assessed":[80],"efficacy":[83,228,312],"APX2104":[85,185,242,289,314,330],"in":[86,114,188,226,249,322],"mice":[88,111,191,254,299],"respectively.":[89],"Neutropenia":[90],"was":[91,186,218],"induced":[92],"150":[94],"mg/kg":[95,103,194,197,217,239,244],"cyclophosphamide":[97],"on":[98,107],"days":[99,108,256,271],"-2/+3":[100],"250":[102],"cortisone":[105],"acetate":[106],"-1/+6.":[109],"Immunocompromised":[110],"infected":[113],"inhalation":[116],"chamber":[117],"via":[118],"12":[119],"mL":[120],"aerosolized":[122],"spores":[123],"CEA10":[127],"at":[128,192,209],"concentration":[130,159],"1x109":[132],"spores/mL":[133],"(Day":[134],"0).":[135],"Treatment":[136],"started":[137],"day":[138,142,200],"+1":[139],"ended":[141],"+7.":[143],"Results":[144],"active-form":[149],"APX2104,":[151],"has":[152],"over":[153],"16-fold":[155],"lower":[156],"minimum":[157],"(MEC)":[160],"when":[161,300],"compared":[162,301],"to":[163,204,302,335],"strains,":[173],"echinocandin-":[175],"azole-resistant":[177],"vivo,":[180,323],"given":[181],"preliminary":[182,326],"pharmacokinetic":[183],"data,":[184],"non-infected":[189],"60":[193,216],"78":[196,213],"once":[198],"per":[199],"(QD).":[201],"Deaths":[202],"due":[203],"seen":[207],"only":[208],"dose":[211,223],"mg/kg,":[214],"set":[219],"safe":[222],"for":[224],"our":[225,278,325],"studies.":[229],"IA-challenged":[231],"neutropenic":[232,298],"mice,":[233],"treatment":[234,290],"either":[236],"posaconazole":[237,316],"(20":[238],"BID)":[240],"or":[241],"(60":[243],"QD)":[245],"equally":[246],"prolonged":[247],"survival":[248,264,279],"14":[250,255,270],"15":[252,268],"(93%)":[253],"post-infection":[257,272],"(p=":[258,273],"0.985).":[259],"Untreatment":[260],"control":[261],"yielded":[262],"3":[266],"(20%)":[269],"<":[274],"0.001).":[275],"Consistent":[276],"studies,":[280],"H&E":[281],"GMS":[283],"histological":[284],"samples":[285],"also":[286],"demonstrated":[287],"that":[288,329],"decreased":[291],"fungal":[292],"burden":[293],"within":[294],"lungs":[296],"untreated":[304],"group.":[305],"Conclusion":[306],"Future":[307],"studies":[308],"will":[309],"test":[310],"azole":[318],"resistant":[320],"strains":[321],"findings":[327],"suggest":[328],"plausible":[333],"solution":[334],"cure":[336],"disease":[338],"combat":[340],"resistance.":[342],"Disclosures":[343],"All":[344],"Authors:":[345],"No":[346],"reported":[347],"disclosures":[348]},"counts_by_year":[],"updated_date":"2026-10-27T15:51:10.671819","created_date":"2021-01-18T00:00:00"}